European Journal Of Haematology · 2003 · 15 citations · 13 references
MedicineImmunologyPathologyClinical ImmunologyImmunopathologyInflammationAutoimmune DiseasesCytokine-mediated PathologyEosinophilic DisordersHematologic PathologyLymph Node PathologyLymphoid Tissue PathologyEnlarged Lymph NodesEosinophilic InfiltratesHypereosinophilic SyndromeInterleukin-5 PathwayPeripheral EosinophiliaTissue Eosinophilia
INTRODUCTION: Castleman's disease (CD), idiopathic lymph-node hyperplasia, is a heterogeneous disease of unknown origin. Although the pathophysiology is yet to be elucidated, interleukin (IL)-6 produced by swollen lymph nodes has been reported to play a crucial role in CD. CASE REPORT: This report presents a case of a 37-yr-old man with CD showing marked elevation of IL-6, hypereosinophilia, and also IL-5 elevation. To date, IL-5 has not been reported to influence CD. However, because in this case the serum concentration of IL-5 produced from swollen lymph nodes paralleled the general symptoms, IL-5, in addition to IL-6, may have played an important role in the disease. DISCUSSION: Although in CD the serum IL-5 level is generally within the normal range, mild eosinophilia is a common complication of the disease. This case indicates that IL-5 can also influence eosinophilia. Taken together, this suggests that there may be a more general association between local production of IL-5 and the pathology of CD.
13
Jean Soulier, L Grollet, Éric Oksenhendler et al. · Blood · 1995 · 2.2K citations · Full text
Localized mediastinal lymph-node hyperplasia resembling thymoma
Benjamin Castleman, Lalla Iverson, V. Pardo Menendez · Cancer · 1956 · 1.6K citations · Full text
Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease
Kazuyuki Yoshizaki, Tadashi Matsuda, Naoki Nishimoto et al. · Blood · 1989 · 904 citations